Try our Advanced Search for more refined results
August 17, 2011
Sandoz Inc. v. Novo Nordisk, Incorporated et al
Case Number:
2:11-cv-13594
Court:
Nature of Suit:
Judge:
Firms
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
August 18, 2011
Sandoz Wants Novo's Prandin Patent Ruled Invalid Again
Generic-drug maker Sandoz Inc. filed a suit Wednesday in Michigan federal court seeking to have Novo Nordisk Inc.'s patent protecting the diabetes drug Prandin declared — for a second time — invalid and unenforceable.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login